The Effect of Collagen Matrix Graft on Postoperative Palatal Fistula Formation After Cleft Palate Repair

October 2, 2023 updated by: Egbunah Uchenna Patrick, Lagos State University

The Effect of Collagen Matrix Graft on Postoperative Palatal Fistula Formation After Cleft Palate Repair: A Randomized Controlled Study

Palatal fistulas are a major burden to surgeons and patients in the management of cleft palate. Their high rate of occurrence and recurrence makes them particularly challenging even to the highly skilled surgeon. Prevention of postoperative palatal fistula is therefore of paramount importance.

Closure of the nasal mucosa under tension has been proposed as a major cause of palatal fistula formation. However, depending on the presentation of the cleft palate, it may be impossible to achieve surgical closure with minimal tension. Till date, there is no universally acceptable method of preventing palatal fistula formation following cleft palate repair. And although the use of pre-surgical appliances such as Latham appliance and the use of local and distant tissues to achieve two layer closure have been proposed, the use of a superpositional collagen graft may also be used to achieve closure of the nasal mucosa with minimal or no tension during cleft palate repair.

Collagen grafts have the added advantage of being more patient friendly compared to the Latham appliance which requires an initial surgery for appliance insertion before surgical cleft palate repair. They are also less technique sensitive compared to the use of local and distant tissues.

The investigators therefore aim to provide high level scientific evidence of the effectiveness of collagen graft in the prevention of postoperative palatal fistula.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lagos, Nigeria, 12003
        • Recruiting
        • Lagos University Teaching Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 months to 2 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Non-syndromic cleft palate
  • Must be between nine months to two years
  • Must have not previously had cleft palate surgery
  • Must consent to participate in the study

Exclusion Criteria:

  • All blood dyscrasias
  • All connective tissue dysfunctions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test group
The intervention will be primary cleft palate repair using resorbable collagen matrix graft as superpositional graft during approximation of the nasal mucosa and muscular layer in cleft palate repair. The collagen graft with be inserted between the nasal mucosa/ muscular layer and the oral mucosa layer during two-flap palatoplasty.
Two-flap palatoplasty used to correct cleft palate defect. The cleft palate is closed by separation of the nasal and the oral mucosa layers. Then approximation of the nasal mucosa layer, muscle layer is secured in the posterior palate and then the oral mucosa layer is secured
Active Comparator: Control group
The intervention will be primary cleft palate repair using two-flap palatoplasty technique without collagen graft
Two-flap palatoplasty used to correct cleft palate defect. The cleft palate is closed by separation of the nasal and the oral mucosa layers. Then approximation of the nasal mucosa layer, muscle layer is secured in the posterior palate and then the oral mucosa layer is secured

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with postoperative palatal fistula
Time Frame: 24 hours post operatively
Palatal fistula will be defined as a patency between the oral and nasal cavities developing postoperatively anywhere along the primary or secondary palate
24 hours post operatively
Number of participants with postoperative palatal fistula
Time Frame: Seven days post operatively
Palatal fistula will be defined as a patency between the oral and nasal cavities developing postoperatively anywhere along the primary or secondary palate
Seven days post operatively
Number of participants with postoperative palatal fistula
Time Frame: Two weeks post operatively
Palatal fistula will be defined as a patency between the oral and nasal cavities developing postoperatively anywhere along the primary or secondary palate
Two weeks post operatively
Number of participants with postoperative palatal fistula
Time Frame: One month post operatively
Palatal fistula will be defined as a patency between the oral and nasal cavities developing postoperatively anywhere along the primary or secondary palate
One month post operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with wound dehiscence
Time Frame: 24 hours post operatively
Wound dehiscence will be defined as partial or total separation of previously approximated and sutured surgical wound edges with or without palatal fistula formation.
24 hours post operatively
Number of participants with wound dehiscence
Time Frame: Seven days post operatively
Wound dehiscence will be defined as partial or total separation of previously approximated and sutured surgical wound edges with or without palatal fistula formation.
Seven days post operatively
Number of participants with wound dehiscence
Time Frame: Two weeks post operatively
Wound dehiscence will be defined as partial or total separation of previously approximated and sutured surgical wound edges with or without palatal fistula formation.
Two weeks post operatively
Number of participants with wound dehiscence
Time Frame: One month post operatively
Wound dehiscence will be defined as partial or total separation of previously approximated and sutured surgical wound edges with or without palatal fistula formation.
One month post operatively
Number of participants with surgical site inflammation
Time Frame: 24 hours post operatively
Surgical site inflammation will be defined as tenderness, redness, swelling and/or differential warmth from surgical site.
24 hours post operatively
Number of participants with surgical site inflammation
Time Frame: Seven days post operatively
Surgical site inflammation will be defined as tenderness, redness, swelling and/or differential warmth from surgical site.
Seven days post operatively
Number of participants with surgical site inflammation
Time Frame: Two weeks post operatively
Surgical site inflammation will be defined as tenderness, redness, swelling and/or differential warmth from surgical site.
Two weeks post operatively
Number of participants with surgical site inflammation
Time Frame: One month post operatively
Surgical site inflammation will be defined as tenderness, redness, swelling and/or differential warmth from surgical site.
One month post operatively
Number of participants with surgical site infection
Time Frame: 24 hours post operatively
Surgical site infection will be defined as tenderness and purulent discharge and/or foul smelling odor from surgical site
24 hours post operatively
Number of participants with surgical site infection
Time Frame: Seven days post operatively
Surgical site infection will be defined as tenderness and purulent discharge and/or foul smelling odor from surgical site
Seven days post operatively
Number of participants with surgical site infection
Time Frame: Two weeks post operatively
Surgical site infection will be defined as tenderness and purulent discharge and/or foul smelling odor from surgical site
Two weeks post operatively
Number of participants with surgical site infection
Time Frame: One month post operatively
Surgical site infection will be defined as tenderness and purulent discharge and/or foul smelling odor from surgical site
One month post operatively
Surgeon satisfaction
Time Frame: within the first 24 hours post operatively
Surgeon satisfaction will assess surgeons' opinion on surgery time (normal/ extended), difficulty of procedure (not difficult/ increased difficulty) and inadvertent tearing of the nasal mucosa (absent/ present).
within the first 24 hours post operatively
Psychology of parents towards surgical treatment
Time Frame: 24 hours post operatively
Psychology of parents towards surgical treatment will assess parents' psychology towards the aesthetic outcome of the cleft palate repair, its effect on their wards feeding and speech ability postoperatively
24 hours post operatively
Psychology of parents towards surgical treatment
Time Frame: Seven days post operatively
Psychology of parents towards surgical treatment will assess parents' psychology towards the aesthetic outcome of the cleft palate repair, its effect on their wards feeding and speech ability postoperatively
Seven days post operatively
Psychology of parents towards surgical treatment
Time Frame: Two weeks post operatively
Psychology of parents towards surgical treatment will assess parents' psychology towards the aesthetic outcome of the cleft palate repair, its effect on their wards feeding and speech ability postoperatively
Two weeks post operatively
Psychology of parents towards surgical treatment
Time Frame: One month post operatively
Psychology of parents towards surgical treatment will assess parents' psychology towards the aesthetic outcome of the cleft palate repair, its effect on their wards feeding and speech ability postoperatively
One month post operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2022

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

July 2, 2022

First Submitted That Met QC Criteria

July 7, 2022

First Posted (Actual)

July 12, 2022

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cleft Palate

Clinical Trials on Two-flap palatoplasty

3
Subscribe